In This Article:
-
Underlying EBIT Growth: 17% increase in portfolio companies.
-
Cash Flow from Operations: Improved by NOK1.9 billion compared to 2023.
-
Organic Growth: 3.3% in Q4.
-
Adjusted Earnings Per Share: Improved by 16% compared to the same quarter last year.
-
Operating Revenues: Grew by 6% to NOK18.8 billion in Q4.
-
Group EBIT: Grew by 25% to NOK2 billion.
-
Rolling 12 Months EBIT Adjust Margin: 10.1% in Q4, an increase of 1.1 percentage points.
-
Total Cash Flow from Operations (Full Year): NOK7.9 billion, an increase of NOK1.9 billion.
-
Cash Conversion: Reached 114% at an aggregated level in 2024.
-
Net Interest Bearing Debt: NOK16 billion, equal to 1.5 times EBITA.
-
Dividend Proposal: Increase to NOK4 per share plus an additional NOK6 per share.
-
Jotun Operating Revenue Growth: 15% increase in Q4.
-
Orkla Foods Organic Growth: 1.1% in Q4.
-
Orkla Snacks Organic Growth: 6.2% in Q4.
-
Orkla Health Organic Growth: 6.2% in Q4.
-
Orkla India Organic Growth: 3.6% in Q4.
-
Orkla Home and Personal Care Organic Growth: 10% in Q4.
-
Warning! GuruFocus has detected 4 Warning Sign with FRA:KP5.
-
This Powerful Chart Made Peter Lynch 29% A Year For 13 Years
-
How to calculate the intrinsic value of a stock?
Release Date: February 13, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Orkla ASA (ORKLF) reported a 17% underlying EBIT growth in its portfolio companies, indicating substantial improvements in profitability.
-
The company improved cash flow from operations by NOK1.9 billion compared to 2023, driven by EBIT growth and better capital discipline.
-
Orkla ASA (ORKLF) plans to increase the ordinary dividend for 2024 and propose an additional dividend of NOK6 per share due to solid performance and asset sales.
-
The sale of Orkla's entire hydropower portfolio for NOK6.1 billion is expected to reduce complexity and align with the company's strategy.
-
Orkla ASA (ORKLF) achieved organic growth of 3.3% in Q4, driven by volume, mix growth, and price increases, with a 13.4% growth in underlying EBIT for consolidated portfolio companies.
Negative Points
-
The Pierre Robert Group has shown weak performance over several years, leading to its sale and strategic repositioning.
-
Market prices for cocoa rose steeply during the quarter, impacting Orkla Snacks negatively due to limited short-term ability to pass on cost increases.
-
Orkla Health faced pressure on contribution margins due to increased raw material prices, particularly for cod liver oil.
-
Orkla India experienced flat organic growth in Q4, with challenges in domestic market sentiment and timing of financial incentives.
-
The European Pizza Company saw a decrease in EBIT due to a write-down of receivables for a limited group of franchisees.